Baby formula company Abbott has secured a deal to reopen its Michigan plan in two weeks to help address the nation’s shortages.
Abbott announced the agreement on Monday with the Food and Drug Administration.
— Washington Examiner (@dcexaminer) May 16, 2022
“Our number one priority is getting infants and families the high-quality formulas they need, and this is a major step toward re-opening our Sturgis facility so we can ease the nationwide formula shortage,” Abbott CEO Robert Ford said.
“We look forward to working with the FDA to quickly and safely re-open the facility,” he added.
BREAKING: Baby formula maker Abbott says agreement will allow it to reopen plant, but it will take at least eight weeks after production resumes to ship new product. https://t.co/5Ht6CfE4DW
— The Associated Press (@AP) May 16, 2022
The FDA also celebrated the new report of the plant’s reopening.
“The FDA expects that the measures and steps it’s taking with infant formula manufacturers and others will mean more and more supply is on the way or on store shelves moving forward,” FDA Commissioner Robert Califf told reporters.